According to DataM Intelligence, the global Liver Cancer Treatment Market was valued at approximately USD 4.58 billion in 2024 and is projected to reach USD 12.88 billion by 2033, exhibiting a robust CAGR of 11.4% during the forecast period 2025-2033. Liver cancer, primarily hepatocellular carcinoma (HCC), is among the leading causes of cancer-related deaths globally, fueled...

The global liver cancer treatment market was valued at US$ 4.58 billion in 2024 and is projected to reach US$ 12.88 billion by 2033, registering a CAGR of 11.4% from 2025 to 2033. The market is expanding steadily due to the rising global incidence of liver cancer, largely driven by risk factors such as hepatitis B and C infections, alcohol consumption, obesity, and non-alcoholic fatty liver...